Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Apr;73(4):340–350. doi: 10.1136/hrt.73.4.340

Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.

F A Bu'Lock 1, M G Mott 1, A Oakhill 1, R P Martin 1
PMCID: PMC483827  PMID: 7756067

Abstract

OBJECTIVES--To examine left ventricular (LV) diastolic function in patients previously treated with anthracycline drugs for childhood malignancy. To consider clinical relevance, relations with systolic dysfunction, and the pathophysiology of anthracycline cardiotoxicity. DESIGN--Cross sectional echocardiographic study of LV function. SETTING--Supraregional centre for paediatric cardiology, principal centre for the treatment of childhood malignancy in southwest England. PATIENTS--226 of 236 patients surviving between 6.5 months and 17 (median 5.3) years from initial anthracycline treatment for childhood malignancy attended for clinical and echocardiographic examination. Cumulative anthracycline doses were between 50 and 750 (median 300) mg/m2. 22 patients had also received cardiac irradiation. METHODS--Detailed assessment of transmitral diastolic pulsed wave Doppler flow patterns along with LV dimensions and systolic function measured by M mode echocardiography. MAIN OUTCOME MEASURES--Peak early (E) and atrial (A) phase filling velocities and EA ratio, time and acceleration and deceleration to and from peak E velocity, velocity integrals and ratio, isovolumic relaxation time (IVRT), and heart rate were measured. Results were examined in relation to LV cavity and posterior wall dimensions and shortening fraction (SF), and compared with paired control data matched for body surface area. RESULTS--Eleven (5%) patients had abnormal effort tolerance. Fifty one (23%) had SF < 30% and SF was inversely correlated with cumulative dose and time from treatment. The relative risk of symptomatic cardiac failure was greatly increased by prior irradiation; > 60% of irradiated patients who received > 400 mg/m2 of anthracycline were symptomatic. Early diastolic filling was relatively normal or enhanced at low anthracycline doses or when SF was preserved, with a shorter IVRT and increased atrial phase filling. Early filling was reduced at higher doses or with reduced SF, with longer IVRT and a further increase in atrial phase filling. A more "restrictive" pattern of diastolic filling (with high E and low A velocities) was seen in some patients, particularly after cardiac irradiation. CONCLUSIONS--Significant abnormalities of diastolic function are associated with anthracycline induced cardiac damage. These are not linearly related to anthracycline dose but appear to reflect the underlying myocardial pathophysiology associated with anthracycline toxicity, which is not demonstrated by the standard M mode echocardiogram. Although the overall clinical significance of such diastolic dysfunction is uncertain, some individual abnormalities may have significant management and therapeutic implications.

Full text

PDF
340

Images in this article

349Image
on p.349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleton C. P., Hatle L. K., Popp R. L. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol. 1988 Apr;11(4):757–768. doi: 10.1016/0735-1097(88)90208-2. [DOI] [PubMed] [Google Scholar]
  2. Appleton C. P., Hatle L. K., Popp R. L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 1988 Aug;12(2):426–440. doi: 10.1016/0735-1097(88)90416-0. [DOI] [PubMed] [Google Scholar]
  3. Billingham M. E., Bristow M. R., Glatstein E., Mason J. W., Masek M. A., Daniels J. R. Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol. 1977 Mar;1(1):17–23. [PubMed] [Google Scholar]
  4. Billingham M. E., Mason J. W., Bristow M. R., Daniels J. R. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978 Jun;62(6):865–872. [PubMed] [Google Scholar]
  5. Bleyer W. A. The impact of childhood cancer on the United States and the world. CA Cancer J Clin. 1990 Nov-Dec;40(6):355–367. doi: 10.3322/canjclin.40.6.355. [DOI] [PubMed] [Google Scholar]
  6. Colan S. D., Borow K. M., Neumann A. Effects of loading conditions and contractile state (methoxamine and dobutamine) on left ventricular early diastolic function in normal subjects. Am J Cardiol. 1985 Mar 1;55(6):790–796. doi: 10.1016/0002-9149(85)90158-4. [DOI] [PubMed] [Google Scholar]
  7. Conroy B., Guthrie W. Endocardial fibroelastosis associated with fatal adriamycin (doxorubicin) cardiomyopathy during treatment of Ewing's sarcoma. Scott Med J. 1983 Jul;28(3):295–299. doi: 10.1177/003693308302800317. [DOI] [PubMed] [Google Scholar]
  8. Fajardo L. F., Eltringham J. R., Steward J. R. Combined cardiotoxicity of adriamycin and x-radiation. Lab Invest. 1976 Jan;34(1):86–96. [PubMed] [Google Scholar]
  9. Fast J., Van Dam I., Heringa A., De Boo T., Alsters J., Hopman J., Daniels O., Van den Merkhof L. Limits of reproducibility of mitral pulsed Doppler spectra. Am J Cardiol. 1988 Apr 15;61(11):891–894. doi: 10.1016/0002-9149(88)90365-7. [DOI] [PubMed] [Google Scholar]
  10. Gottdiener J. S., Katin M. J., Borer J. S., Bacharach S. L., Green M. V. Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N Engl J Med. 1983 Mar 10;308(10):569–572. doi: 10.1056/NEJM198303103081005. [DOI] [PubMed] [Google Scholar]
  11. Hancock S. L., Donaldson S. S., Hoppe R. T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993 Jul;11(7):1208–1215. doi: 10.1200/JCO.1993.11.7.1208. [DOI] [PubMed] [Google Scholar]
  12. Hausdorf G., Morf G., Beron G., Erttmann R., Winkler K., Landbeck G., Keck E. W. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Br Heart J. 1988 Oct;60(4):309–315. doi: 10.1136/hrt.60.4.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heusch G. Alpha-adrenergic mechanisms in myocardial ischemia. Circulation. 1990 Jan;81(1):1–13. doi: 10.1161/01.cir.81.1.1. [DOI] [PubMed] [Google Scholar]
  14. Isner J. M., Ferrans V. J., Cohen S. R., Witkind B. G., Virmani R., Gottdiener J. S., Beck J. R., Roberts W. C. Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy. Am J Cardiol. 1983 Apr;51(7):1167–1174. doi: 10.1016/0002-9149(83)90364-8. [DOI] [PubMed] [Google Scholar]
  15. Labovitz A. J., Pearson A. C. Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insights. Am Heart J. 1987 Oct;114(4 Pt 1):836–851. doi: 10.1016/0002-8703(87)90795-2. [DOI] [PubMed] [Google Scholar]
  16. Lee B. H., Goodenday L. S., Muswick G. J., Yasnoff W. A., Leighton R. F., Skeel R. T. Alterations in left ventricular diastolic function with doxorubicin therapy. J Am Coll Cardiol. 1987 Jan;9(1):184–188. doi: 10.1016/s0735-1097(87)80099-2. [DOI] [PubMed] [Google Scholar]
  17. Mortensen S. A., Olsen H. S., Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J. 1986 Mar;55(3):274–282. doi: 10.1136/hrt.55.3.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mortensen S. A., Olsen H. S., Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J. 1986 Mar;55(3):274–282. doi: 10.1136/hrt.55.3.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nishimura R. A., Abel M. D., Hatle L. K., Tajik A. J. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc. 1989 Feb;64(2):181–204. doi: 10.1016/s0025-6196(12)65673-0. [DOI] [PubMed] [Google Scholar]
  20. Nishimura R. A., Housmans P. R., Hatle L. K., Tajik A. J. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part I. Physiologic and pathophysiologic features. Mayo Clin Proc. 1989 Jan;64(1):71–81. doi: 10.1016/s0025-6196(12)65305-1. [DOI] [PubMed] [Google Scholar]
  21. Oniki T., Hashimoto Y., Shimizu S., Kakuta T., Yajima M., Numano F. Effect of increasing heart rate on Doppler indices of left ventricular performance in healthy men. Br Heart J. 1992 Oct;68(4):425–429. doi: 10.1136/hrt.68.10.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith S. A., Stoner J. E., Russell A. E., Sheppard J. M., Aylward P. E. Transmitral velocities measured by pulsed Doppler in healthy volunteers: effects of acute changes in blood pressure and heart rate. Br Heart J. 1989 Apr;61(4):344–347. doi: 10.1136/hrt.61.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Spirito P., Maron B. J., Verter I., Merrill J. S. Reproducibility of Doppler echocardiographic measurements of left ventricular diastolic function. Eur Heart J. 1988 Aug;9(8):879–886. doi: 10.1093/oxfordjournals.eurheartj.a062582. [DOI] [PubMed] [Google Scholar]
  24. Stewart R. A., Joshi J., Alexander N., Nihoyannopoulos P., Oakley C. M. Adjustment for the influence of age and heart rate on Doppler measurements of left ventricular filling. Br Heart J. 1992 Dec;68(6):608–612. doi: 10.1136/hrt.68.12.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stoddard M. F., Pearson A. C., Kern M. J., Ratcliff J., Mrosek D. G., Labovitz A. J. Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation. 1989 Jun;79(6):1226–1236. doi: 10.1161/01.cir.79.6.1226. [DOI] [PubMed] [Google Scholar]
  26. Thomas J. D., Weyman A. E. Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and physiology. Circulation. 1991 Sep;84(3):977–990. doi: 10.1161/01.cir.84.3.977. [DOI] [PubMed] [Google Scholar]
  27. Wilcox R. G., James P. D., Toghill P. J. Endomyocardial fibrosis associated with daunorubicin therapy. Br Heart J. 1976 Aug;38(8):860–863. doi: 10.1136/hrt.38.8.860. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES